Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at the University of Alabama at Birmingham is evaluating neuroinflammation in Parkinson disease using TSPO-PET imaging; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: RECRUITING